pillbase.ru

ELELYSO

Active substance: taliglucerase alfa

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TALIGLUCERASE ALFA 200 U/5mL

United StatesActive

Marketing holder: Pfizer Laboratories Div Pfizer Inc

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Элисо
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 200 ЕД, 200 ЕД (original in Russian, GRLS)
    ЛП-004410
    Пфайзер Инк
  • Элисо
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 200 ЕД, 200 ЕД (original in Russian, GRLS)
    ЛП-№(013827)-(ГП-RU)
    Пфайзер Инк
EU 1
  • Elelyso
    taliglucerase alfa
    EMEA/H/C/002250
    Pfizer Ltd.   
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-2fdd-75c7-9d26-a8400d3c20fc,01a120c3-da1e-74b2-87ae-129b044c7e1c;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12092-e2d9-7a36-965b-fc9f7ba749f8;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0069-0106
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 0069-0106 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0069-0106 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0069-0106 · Verified 2026-10-09 · open in source